NCT00608725View on ClinicalTrials.gov

Pathophysiology of Orthostatic Intolerance

NAActive, not recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
TachycardiaPostural Orthostatic Tachycardia Syndrome
Interventions
RADIATION

DAXOR

131-I-Human Serum Albumin Blood Volume Assessment Kit

PROCEDURE

QSweat

Quantitative Sweat Testing

DRUG

Intrinsic Heart Rate

Atropine 0.04 mg/kg IV in divided doses Propranolol 0.2 mg/kg IV in divided doses

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors
lead

Satish R. Raj

OTHER

NCT00608725 - Pathophysiology of Orthostatic Intolerance | Biotech Hunter | Biotech Hunter